KOD ▲ +17.2% - Kodiak Sciences Inc. $KOD KOD - Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration 25-SEP-2026 06:02 PM ET